University of Vermont: all 221 studies
Page 3 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic SyndromeCompletedNCT00395265
- Anxiety Sensitivity Program for Smoking CessationCompletedNCT00387049Not applicable
- Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly WomenStatus unknownNCT00337064Phase 1/2
- Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00293501Phase 1/2
- A Telephone Feedback System for Prevention of Chronic Pain RelapseCompletedNCT00266773Not applicable
- Internet Assisted Obesity TreatmentCompletedNCT00265954Not applicable
- Weight Loss on the Web: A Pilot Study Comparing a Commercial Website to a Structured Behavioral InterventionCompletedNCT00263172Not applicable
- Evaluation of an Outpatient Modified Prescription FormCompletedNCT00256594Not applicable
- Outpatient Prescription Errors: Detection, Analysis, and Impact on SafetyCompletedNCT00256568
- Quetiapine for the Treatment of Insomnia in Alzheimer's DiseaseStatus unknownNCT00232570Not applicable
- Using Telephone Technology to Prevent Relapse After Alcoholism TreatmentCompletedNCT00132795Phase 2
- Epidemiology of Vascular Inflammation & AtherosclerosisCompletedNCT00087893
- Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaCompletedNCT00005579Phase 2
- Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's DiseaseCompletedNCT00004423Not applicable
- Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22CompletedNCT00000240Phase 2
- Alternate Day Buprenorphine Administration, Phase XI - 16CompletedNCT00000234Phase 2
- Alternate Day Buprenorphine Administration, Phase IX - 14CompletedNCT00000232Phase 2
- Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12CompletedNCT00000230Phase 2
- Buprenorphine Detox With Two Types of Treatment. BBD II - 11CompletedNCT00000229Phase 2
- Alternate-Day Buprenorphine Administration. Phase VIII - 9CompletedNCT00000227Phase 2
- Buprenorphine Dose Alteration Study - 1CompletedNCT00000219Phase 1